Coronavirus Update: Fujifilm Drug Shows Promise, Arrowhead Halts Trial Screening, Novartis Unveils COVID-19 Measures

First Signs Of Impact on Clinical Trials

 
• By Andrew McConaghie

Flu drug produces encouraging results in Chinese trials, while Novartis CEO Vas Narasimhan shows his public health background with package of measures.

Apple
The Apple Store in downtown New York, now virtually deserted as the city's inhabitants stay at home to beat COVID-19

More from COVID-19

More from Scrip